Wednesday , October 20 2021

Anti-cancer drugs. 2x Survival Rate – Fresh


Breast cancer is the most common type of cancer among Thai women and women around the world. Currently, the number of people with this disease is increasing each year. The early stages of breast cancer often do not show signs or symptoms. The patient is aware that cancer spreads to third to fourth. Breast cancer treatment Previous surgery, chemotherapy, antihormone treatment, but in the last 1 year there is another alternative treatment. Following the United States Pfizer. The innovative drug for breast cancer in the spread and spread. In Thailand, this medicine has been approved by the drug. During the past year, Pfizer Thailand donated this drug to the Thai Oncological Association last year. For the treatment of 50 patients with metastatic breast cancer, Associate Professor Dr. Viroj Sriroonpong, Head of Medical Excellence Center Cancer Complete King Chulalong Corn Memorial Hospital The president of the Thai Oncology Association said the drug is a drug for cancer that inhibits the effect of CDK 4/6, which is approved by the Food and Drug Administration as the first drug. The first line of patients with advanced or metastatic breast cancer. ER + / HER 2 menopause. Dr Viroj said that the drug has two formulas that will be used differently. The first formulation is used by patients who have never received any hormonal treatment. […]

Post anti-cancer drug. Increase survival rate 2 times emerged first on nations.

Source link